Cardiovascular Pathology
Volume 20, Issue 4 , Pages 195-203 , July 2011

iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach

  • Ida Perrotta

      Affiliations

    • Department of Ecology, University of Calabria, Rende, Cosenza, Italy
    • Corresponding Author InformationCorresponding author. Department of Ecology, University of Calabria, Arcavacata di Rende (Cosenza) 87036, Italy. Tel.: +39 0984 492976, +39 3471734173; fax: +39 0984 492986.
    • ,
  • Elvira Brunelli

      Affiliations

    • Department of Ecology, University of Calabria, Rende, Cosenza, Italy
    • ,
  • Alfonso Sciangula

      Affiliations

    • Department of Cardiothoracic Surgery and Cardiology, Sant'Anna Hospital, Catanzaro, Italy
    • ,
  • Francesco Conforti

      Affiliations

    • Department of Pathology, School of Medicine, University Magna Graecia, Catanzaro, Italy
    • ,
  • Enrico Perrotta

      Affiliations

    • Department of Ecology, University of Calabria, Rende, Cosenza, Italy
    • ,
  • Sandro Tripepi

      Affiliations

    • Department of Ecology, University of Calabria, Rende, Cosenza, Italy
    • ,
  • Giuseppe Donato

      Affiliations

    • Department of Pathology, School of Medicine, University Magna Graecia, Catanzaro, Italy
    • ,
  • Mauro Cassese

      Affiliations

    • Department of Cardiothoracic Surgery and Cardiology, Sant'Anna Hospital, Catanzaro, Italy

Received 7 August 2009 ,Revised 2 October 2009 ,Accepted 2 June 2010.

References 

  1. Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res. 1999;43:509–520
  2. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev. 2003;8:71–86
  3. Böger RH, Tsikas D, Bode-Böger SM, Phivthong-ngam L, Schwedhelm E, Frölich JC. Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of l-[guanidino-15N2]-arginine to 15N-labeled nitrate by gas chromatography–mass spectrometry. Nitric Oxide. 2004;11:1–8
  4. Liu HR, Tao L, Gao E, Lopez BL, Christopher TA, Willette RN, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res. 2004;62:135–144
  5. Perrotta I, Brunelli E, Sciangula A, Zuccalà V, Donato G, Tripepi S, et al. Inducible and endothelial nitric oxide synthase expression in human atherogenesis: an immunohistochemical and ultrastructural study. Cardiovasc Pathol. 2009;18:361–368
  6. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342:249–268
  7. Hans CP, Zerfaoui M, Naura AS, Catling A, Boulares HA. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability. Cardiovasc Res. 2008;78:429–439
  8. Naura AS, Datta R, Hans CP, Zerfaoui M, Rezk BM, Errami Y, et al. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J. 2009;33:252–262
  9. Park EM, Cho S, Frys K, Racchumi G, Zhou P, Anrather J, et al. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Stroke. 2004;35:2896–2901
  10. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 2002;106:927–932
  11. Zhang C, Yang J, Jennings LK. Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. Am J Physiol. 2004;287:H659–H666
  12. Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, et al. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice. Circulation. 2007;115:2442–2450
  13. Coons AH, Leduc EH, Connolly JM. Studies on antibody production: a method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J Exp Med. 1955;102:49–60
  14. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 1998;97:2494–2498
  15. D'Uscio LV, Baker TA, Smith LA, Weiler D, Katusic ZS. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:1017–1022
  16. Behr D, Rupin A, Fabiani JN, Verbeuren TJ. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis. 1999;142:335–344
  17. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S. Evidence for induction of non-endothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993;21:841–845
  18. Ravalli S, Albala A, Ming M, Szabolcs M, Barbone A, Michler RE, et al. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation. 1998;97:2338–2345
  19. Esaki T. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis. 1997;128:39–46
  20. Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, et al. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur J Neurosci. 2004;20:1461–1472
  21. Soriano FG, Virág L, Jagtap P, Szabó E, Mabley JG, Liaudet L, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose)polymerase activation. Nat Med. 2001;7:108–113
  22. Bloch W, Mehlhorn U. Poly-adenosine diphosphate–ribose polymerase inhibition for myocardial protection: pathophysiologic and physiologic considerations. J Thorac Cardiovasc Surg. 2004;128:323–324
  23. Graziania G, Szabób C. Clinical perspectives of PARP inhibitors. Pharmacol Res. 2005;52:109–118
  24. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A. 1996;93:1753–1758
  25. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140–141:105–112
  26. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A. 1997;94:6954–6958
  27. Pacher P, Szabo C. Role of the peroxynitrite–poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol. 2008;173:2–13
  28. Scovassi AI. Mitochondrial poly(ADP-ribosylation): from old data to new perspectives. FASEB J. 2004;18:1487–1488
  29. Lai Y, Chen Y, Watkins SC, Nathaniel PD, Guo F, Kochanek PM, et al. Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem. 2007;104:1700–1711
  30. Virág L, Salzman AL, Szabó C. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol. 1998;161:3753–3759
  31. Tanaka S, Takehashi M, Iida S, Kitajima T, Kamanaka Y, Stedeford T, et al. Mitochondrial impairment induced by poly(ADP-ribose) polymerase-1 activation in cortical neurons after oxygen and glucose deprivation. J Neurosci. 2005;95:179–190
  32. Chen M, Xiao CY, Zsengeller Z, Szabo C. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. J Pharmacol Exp Ther. 2004;310:498–504
  33. Chen M, Zsengellér Z, Xiao CY, Szabó C. Mitochondrial-to-nuclear translocation of apoptosis inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose)polymerase-1. Cardiovasc Res. 2004;63:682–688
  34. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91:7–11
  35. Ham YM, Lim JH, Na HK, Choi JS, Park BD, Yim H, et al. Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells. J Pharmacol Exp Ther. 2006;319:1276–1285
  36. Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT, Schumacker PT. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res. 2002;91:719–726

 Financial support: The authors declare that no funding was available for this work.

PII: S1054-8807(10)00074-8

doi: 10.1016/j.carpath.2010.06.002

Cardiovascular Pathology
Volume 20, Issue 4 , Pages 195-203 , July 2011

Article Tools

* Image Usage & Resolution